Acadia Pharmaceuticals Stock
Acadia Pharmaceuticals Stock
Acadia Pharmaceuticals took a tumble today and lost -€0.420 (-3.020%).
The stock is one of the favorites of our community with 28 Buy predictions and 1 Sell predictions.
With a target price of 31 € there is potential for a 128.95% increase which would mean more than doubling the current price of 13.54 € for Acadia Pharmaceuticals.
Our community identified positive and negative aspects for Acadia Pharmaceuticals stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Acadia Pharmaceuticals stock. On the other hand our users think that "EBIT growth" could be a problem in the future.
Pros and Cons of Acadia Pharmaceuticals in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Acadia Pharmaceuticals vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Acadia Pharmaceuticals | -3.020% | -3.458% | -13.289% | -41.638% | -52.324% | -26.051% | -38.913% |
Ironwood Pharmaceuticals | -0.900% | 0.917% | -24.138% | -46.078% | -46.078% | -41.489% | - |
Novocure Ltd | -0.580% | -4.920% | 76.819% | -69.807% | 42.137% | -87.839% | - |
Iovance Biotherapeutics Inc. | -0.550% | -11.212% | -25.833% | 0.392% | 4.867% | -45.918% | - |
Comments
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at HC Wainwright from $33.00 to $27.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ACAD provided by MarketBeat
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Citigroup Inc. from $30.19 to $30.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ACAD provided by MarketBeat
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $37.00 price target on the stock.
Show more
Ratings data for ACAD provided by MarketBeat